Activist Investor Starboard Unhappy With Bristol-Myers’ Deal to Buy Celgene
Wall Street Journal -

Activist investor Starboard is unhappy with Bristol-Myers’ deal to buy Celgene. The drugmaker’s fifth-largest shareholder, Dodge & Cox, is also unhappy with the deal.

Read this story at

Loading...

Related Articles